|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Most studies of bilateral lung volume reduction surgery (LVRS) report increases in arterial oxygenation (PaO2). Some suggest this results from an increased alveolar ventilation, but others imply that
ventilation-perfusion heterogeneity is reduced. We measured arterial blood gases (ABGs) on air before and 3 mo following LVRS in 46 patients (61% of eligible patients), estimate the difference between alveolar and arterial O2 (AaPO2), and correlated the changes observed with preoperative
ABGs, and with pre-and postoperative pulmonary function. The mean ± SD change in PaO2 and
AaPO2 was +3 ± 10 mm Hg (p = 0.058) and +1 ± 11 mm Hg (p = NS), respectively, and the range of
change was large (
17 to +29 mm Hg and
24 to +23 mm Hg, respectively). The mean change in
PaCO2 was
3 ± 5 mm Hg (p < 0.05) and ranged from
11 to +5 mm Hg. Changes in PaO2 and AaPO2
were poorly correlated with changes in PaCO2 or with pre- or postoperative pulmonary function. Although some patients had a marked improvement in ABGs following LVRS, almost as many deteriorated. On average, only minimal effects were seen. Although mean alveolar ventilation improved
somewhat, the effect of LVRS on PaO2 primarily resulted from alterations in ventilation-perfusion heterogeneity.
| |
INTRODUCTION |
|---|
|
|
|---|
In the initial article describing bilateral lung volume reduction surgery (LVRS) done by median sternotomy for patients with emphysema, Cooper and colleagues (1) reported that the mean ± SD PaO2 increased from 64 ± 6.5 mm Hg (n = 18, breathing air) to 70 mm Hg (n = 8, no SD reported, p < 0.05) with no change in the PaCO2 when both were remeasured 6 mo following the operation. Little and colleagues (2) observed similar but less marked changes in 14 patients who either had giant bullectomy (n = 3), LVRS via sternotomy with staple resection (n = 6) or unilateral thoracoscopic laser ablation (n = 5) (room air PaO2 increasing from 59 ± 2 to 63 ± 2, p < 0.05, no change in PaCO2). Similar trends were reported by Daniel and colleagues (3) in 17 patients, although the changes in PaO2 and PaCO2 did not reach statistical significance. The lack of change in PaCO2 in these studies implies that LVRS improves oxygenation without improving alveolar ventilation, suggesting that ventilation-perfusion heterogeneity is reduced.
The results of other studies, however, would link much of the change in oxygenation following LVRS to an increase in alveolar ventilation. Miller and colleagues (4) reported that the mean PaO2 increased from 62 to 70 mm Hg (n = 40), while the mean PaCO2 decreased from 43 to 40 mm Hg. Similar findings were reported by Tschernko and colleagues (5) (PaO2 increasing from 56 ± 3 to 66 ± 3 mm Hg with PaCO2 decreasing from 45 ± 1 to 38 ± 1 mm Hg, n = 12).
There are similar disparities in the effect of unilateral LVRS on gas exchange. Roué and colleagues (6) found that the improvement in PaO2 was largely the result of an improvement in alveolar ventilation (i.e., PaO2 increasing from 54 ± 7 to 61 ± 8 mm Hg with PaCO2 decreasing from 45 ± 5 to 41 ± 7 mm Hg, n = 13), but Naunheim and colleagues (7) reported that PaO2 increased from 59 ± 9 to 67 ± 11 mm Hg while PaCO2 did not change (n = 12). Both Keenan and colleagues (8) and Sciurba and colleagues (9) reported that PaO2 did not change while PaCO2 decreased (n = 40 and 20, respectively). Hazelrigg and colleagues (10) found no significant changes in either the PaO2 or the PaCO2 (n = 91, with results from some of the patients included in other reports cited).
The purpose of this study was to measure the effects of LVRS (done through a median sternotomy with stapled resection) on arterial blood gases and to relate the changes observed to a number of theoretical outcomes from the operation.
| |
METHODS |
|---|
|
|
|---|
Between October 1994 and June 1996, 76 patients with severe airflow limitation, airtrapping, and roentgenographic evidence of emphysema underwent LVRS at our institution. Screening criteria for entry into our program included: (1) evidence of severe airflow limitation (15% < FEV1 < 35% predicted); (2) evidence of severe hyperinflation (total lung capacity > 120% or residual volume > 150% predicted); (3) age < 75 yr; (4) smoking cessation for at least 3 mo; (5) absence of substantive daily sputum production; (6) computed tomographic evidence of emphysema; and (7) absence of other comorbid conditions. Any patient with evidence of pulmonary hypertension by electrocardiogram, chest roentgenograms, or physical examination underwent echocardiography to evaluate pulmonary arterial pressures; if the echocardiogram revealed pulmonary hypertension or was equivocal, right heart catheterization was performed. No patient underwent pulmonary rehabilitation either before or after the operation.
Arterial blood gases were measured with the patients slightly recumbent (i.e., approximately 75°), breathing air for a minimum of 10 min before and 3 mo after bilateral LVRS, which was performed through a median sternotomy with buttressed stapling as described by
Cooper and colleagues (1). The alveolar-to-arterial oxygen tension
difference (AaPO2) was calculated using the measured PaO2 with the
alveolar oxygen tension (PAO2 calculated from the alveolar gas equation assuming r = 0.8: PAO2 = PIO2
PaCO2/R, where R = gas exchange ratio and PIO2 = partial pressure of inspired oxygen.
Data are presented as means ± SD, comparisons are made by paired t testing, and correlations were sought using linear regressions (p < 0.05 was considered significant).
| |
RESULTS |
|---|
|
|
|---|
The demographics and pulmonary function tests of the 46 patients studied are presented in Table 1. The degree of airflow limitation and gas trapping observed in our population was similar to that of patients undergoing LVRS in other institutions (1). The population represents 61% of a consecutive series of 76 patients undergoing LVRS at the University of Washington Medical Center between September 1994 and June 1996. Arterial blood gases were measured at mean ± SD 113 ± 88 d (i.e., a mean of approximately 3 mo prior to the operation).
|
The changes in PaO2 and PaCO2 measured 3 mo following
LVRS are presented in Figure 1. The mean change in PaO2
was +3 ± 10 mm Hg (p = 0.58), but the range of change was
considerable (
17 to +29 mm Hg). The mean ± SD change in
PaCO2 was
3 ± 5 mm Hg (p < 0.05) with a range of
11 to
+5 mm Hg. The mean ± SD change in AaPO2 was +1 ± 11 mm Hg (p = NS) with a range of
24 to +23 mm Hg. There
was no correlation between the change in PaCO2 and the
change in PaO2 or AaPO2 (Figures 1 and 2).
|
|
We found no significant correlation between the changes in PaCO2, PaO2, or the AaPO2 and the preoperative PaCO2, PaO2, AaPO2, FEV1, residual volume (RV), total lung capacity (TLC) (all expressed in liters or as percent predicted), or the diffusing capacity for carbon monoxide (DLCO). Changes in pulmonary function resulting from LVRS are summarized in Table 2. We found no correlation between the changes in PaCO2, PaO2, or AaPO2 and the changes in FEV1, RV, or TLC (measured in liters or in percent predicted), or with the change in the DLCO occurring as a result of the operation.
|
| |
DISCUSSION |
|---|
|
|
|---|
The important findings of this study are that (1) LVRS can improve or worsen arterial blood gases; (2) although the mean changes in PaO2 and PaCO2 are minimal, the range of change in blood gases is considerable; (3) on average, there seems to be a small improvement in alveolar ventilation; and (4) the major beneficial and detrimental effects of LVRS on PaO2 seem to occur via changes in ventilation-perfusion heterogeneity.
We were able to obtain follow-up studies on only 61% of patients who were eligible at the 3-mo time point despite contacting those who elected not to return on several occasions. Although more complete and/or more prolonged follow-up might alter the mean changes in the PaCO2, PaO2, and/or the AaPO2 observed, it will not alter the observation that these variables can both improve and worsen as a result of LVRS, and that the range of change is considerable. Changes in gas exchange seen at 3 mo may under- or overestimate what occurs later. Although the effect of LVRS on lung mechanics seems to peak at 6 mo (11), the effect on gas exchange may reach a maximum at 3 mo (4).
We assumed that R was equal to 0.8 when calculating the AaPO2 both before and after LVRS. In an earlier study on the effects of LVRS on cardiopulmonary exercise physiology, we measured resting R values of 0.81 ± 0.79 and 0.83 ± 0.78 in 24 patients before and after the operation (12). Accordingly, our assumption seems justified.
Gas Exchange Abnormalities in Patients with Chronic Obstructive Pulmonary Disease
At a constant barometric pressure and fraction of inhaled O2,
changes in the PaO2 can result from alterations in shunt, O2 uptake, diffusion capacity, alveolar ventilation (
A), ventilation-perfusion heterogeneity, and/or mixed venous O2 tension
(P
O2).
Alterations in shunt and/or diffusion. Wagner and colleagues (13) used the multiple inert gas elimination method to characterize gas exchange in 23 patients with chronic obstructive pulmonary disease (COPD). Three patterns of ventilation- perfusion heterogeneity were observed: (1) extensive regions of high ventilation-perfusion (i.e., ventilation-perfusion > 3), with few regions of low ventilation-perfusion and no shunt (i.e., the high "H" pattern); (2) large regions of low ventilation-perfusion with few regions of high ventilation-perfusion and no shunt (i.e., the low or "L" pattern); and (3) a pattern consisting of both low and high ventilation-perfusion regions, again with no shunt. Diffusion abnormalities were not found to contribute to the hypoxemia. Almost all of their patients with emphysema (as opposed to those with bronchitis) had the H pattern of ventilation-perfusion heterogeneity. Accordingly, of the pathophysiologic mechanisms by which LVRS might improve the PaO2, reductions in shunt and/or an improvement in diffusion can be eliminated as patients with emphysema have little-to-no shunt, and abnormal diffusion does not contribute to the hypoxemia observed, at least at rest (13). The PaO2 could decrease, however, if shunt developed or if diffusion worsened.
Change in alveolar ventilation. The change in PaCO2 of
3 ± 5 mm Hg that we observed indicates that, on average, patients increased their alveolar ventilation and/or decreased their
CO2 production following LVRS. We have previously observed (12, 14) that resting minute ventilation and CO2 production were unchanged following LVRS, but that dead space
volume/tidal volume (VD/VT) decreased slightly but significantly (
4%, p < 0.05). Accordingly, the decrease in PaCO2
that we observed can be attributed to a reduction in VD/VT
that results from LVRS.
Changes in ventilation-perfusion heterogeneity. Although significant mean changes in PaO2 and AaPO2 were not observed, many patients had considerable changes in these variables, indicating that LVRS can worsen or improve ventilation/perfusion heterogeneity. The mechanisms by which these opposing effects might occur can be demonstrated by using the CO2-O2 diagram. The theory was originally described by Rahn (15) and independently by Riley and Cournand (16) to depict the effect of ventilation-perfusion heterogeneity on inefficiency of O2 and CO2 exchange. The CO2-O2 diagram shows a curve describing the PO2 of all possible alveoli in the lungs with a given inspired gas and mixed venous blood PO2 and PCO2. The alveolar points for the curve are calculated by assuming an identical gas exchange ratio for both alveolar gas and pulmonary capillary blood in each alveolus. A brief explanation of the method used for constructing such a curve can be found in Hlastala and Berger (17).
The hypothetical CO2-O2 diagram for a patient with the H pattern of ventilation-perfusion distribution is shown with a four-compartment lung (shunt, low ventilation-perfusion, high ventilation-perfusion, and dead space) in Figure 3. The alveolar point (A) is determined from a ventilation-weighted mean of the values from the two alveolar regions that receive ventilation (joined by the solid line). The mixed exhaled point (E) is the ventilation-weighted average of gas from the alveolar point and the dead space. The arterial point (a) is determined from the perfusion-weighted mean of blood gas contents coming from the three regions that receive perfusion (not obtainable graphically). The horizontal difference on the x-axis between (A) and (a) is the AaPO2, in this case equal to 41.5 mm Hg. Notice the large vertical difference between (a) and (A) on the y-axis indicating a large aAPCO2, which is a result of the substantial ventilation going to the high ventilation-perfusion region.
|
The hypothetical CO2-O2 diagram for a patient with the L pattern of ventilation-perfusion distribution is shown with a four-compartment lung (shunt, low ventilation-perfusion, high ventilation-perfusion, and dead space) in Figure 4. For this example, the AaPO2 is equal to 64 mm Hg. The AaPO2 is larger in this case because a large fraction (45%) of the blood flow goes through a region with very low oxygen content (only slightly greater than mixed venous blood oxygen content). In the L pattern, the aAPCO2 is relatively small because of the absence of a high ventilation-perfusion region.
|
When hypoxemia results from blood perfusing areas of low
ventilation-perfusion, improvements in PaO2 can result only
from: (1) redistributing ventilation away from high ventilation-perfusion and/or dead space regions toward regions of
low ventilation-perfusion; (2) redistributing perfusion away
from the low ventilation-perfusion regions toward regions of
higher ventilation-perfusion; and/or (3) improving the P
O2.
LVRS can improve or worsen gas exchange and can narrow or
widen the AaPO2, depending on the relative degree of ventilation and perfusion going to the resected areas and the resulting ventilation-perfusion of the regions to which ventilation
and/or perfusion redistribute.
If perfusion greatly exceeded ventilation in an area that was resected, this low ventilation-perfusion region would be eliminated and whatever perfusion was going to the area would redistribute elsewhere (assuming that cardiac output remained unchanged) (Figure 4). If the perfusion were redistributed to an area of high ventilation-perfusion, the ventilation-perfusion ratio in that region would normalize and the resulting PaO2 and AaPO2 would improve. If the perfusion redistributed to an area of low ventilation-perfusion, the ventilation-perfusion ratio in that region would worsen, reducing the PaO2 and increasing the AaPO2. The PaO2, the AaPO2 and the PaCO2 would improve, worsen, or remain unchanged depending on whether the ventilation-perfusion ratio of the region that was now receiving more perfusion ended up being higher, lower, or the same as the ventilation-perfusion ratio of the region of lung that was resected.
If the areas resected were receiving any substantive degree of perfusion, the pulmonary arterial pressure might increase (as has been suggested by preliminary data reported by Weg and colleagues [18]).
If ventilation greatly exceeded perfusion and if resection
removed this high ventilation-perfusion region, ventilation
would redistribute to other areas (assuming that alveolar ventilation [
A] remained unchanged). If
A redistributed to an
area of low ventilation-perfusion, the ventilation-perfusion
ratio in this region would improve, with resulting improvements in the PaO2, AaPO2, and PaCO2 (Figure 4). If
A redistributed to areas of high ventilation-perfusion and/or dead
space, the ventilation-perfusion in these region would increase further. As above, the PaO2, the AaPO2, and the PaCO2
would improve, worsen, or remain unchanged, depending on
whether the ventilation-perfusion ratio of the region that received more alveolar ventilation ended up being higher, lower,
or the same as the ventilation-perfusion ratio of the region of
lung that was resected.
If the areas resected received any substantive degree of alveolar ventilation, the resulting PaCO2 could increase if the mechanics of the remaining lung precluded a sufficient increase in its alveolar ventilation.
For the hypothetical lungs shown in Figures 3A and 4A, resection of the abnormal region, allowing all alveolar perfusion and ventilation to go to the remaining alveolar region, results in a much more homogeneous ventilation-perfusion distribution and a marked improvement in the AaPO2. In the H pattern, lung resection of the high ventilation-perfusion regions results in a reduction of AaPO2 from 41.5 to 12.2 mm Hg (Figure 3B). In the L pattern, lung resection of the low ventilation-perfusion regions results in a reduction of AaPO2 from 64 to 3.4 mm Hg (Figure 4B). In the relatively homogeneous lungs shown in Figure 3B and Figure 4B, the AaPO2 is comparably small, but is larger in Figure 3B because of the greater assumed shunt (3% versus 1%). If any perfusion were redistributed to this shunt region, gas exchange would worsen.
In both of the cases illustrated in Figures 3 and 4, resection of any portion of the lung deviating most from the normal ventilation-perfusion of approximately 1.0 narrows the remaining ventilation-perfusion heterogeneity. If the resected sections of the lung consisted of relatively normal ventilation- perfusion regions, and if the perfusion and/or ventilation of these regions were redistributed such that ventilation-perfusion heterogeneity of the remaining lung worsened, the AaPO2 would increase and the PaO2 would fall.
Finally, many centers routinely obtain perfusion lung scans prior to LVRS in an attempt to target areas for resection that have little to no perfusion. Accordingly, the fraction of total perfusion that might be redirected following resection generally could be exceedingly small, and the resulting changes in ventilation-perfusion could be trivial.
Changes in P
O2 . Changes in P
O2 would affect gas exchange in areas of low ventilation-perfusion rates and/or
shunt. Although P
O2 data have not been reported in patients
undergoing LVRS, Albert and colleagues (19) found values
that were below normal (35.8 ± 0.7 mm Hg, with venous oxygen saturation of 66.9 ± 1.0%) in 30 patients with stable
COPD who had somewhat less severe airflow limitation than
those reported here. P
O2 could be low in patients undergoing
LVRS and might improve or worsen following the procedure,
if the operation altered work of breathing (9, 11, 20, 21) and/or
cardiac output and oxygen delivery (as a function of changes
in mean pleural pressure and the level of auto-positive end-
expiratory pressure (9).
In summary, LVRS can improve and worsen arterial blood gases, and the changes do not correlate with the effects of the operation on lung mechanics. Patients being evaluated for the procedure should be advised that, although oxygenation might improve following the operation, it is possible, and perhaps equally likely, that it will worsen. They could also be advised that, based on the information that is presently available, it is not possible to predict prior to the procedure who will have an improvement in oxygenation and who will not.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Richard K. Albert, M.D., Denver Health Medical Center, 777 Bannock St., MC-4000, Denver, CO 80204-4507.
(Received in original form May 23, 1997 and in revised form February 24, 1998).
| |
References |
|---|
|
|
|---|
1. Cooper, J. D., E. P. Trulock, A. N. Triantafillou, G. A. Patterson, M. S. Pohl, P. A. Deloney, R. S. Sundareson, and C. L. Roper. 1995. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J. Thorac. Cardiovasc. Surg. 103: 1119-1126 [Abstract].
2. Little, A. G., J. A. Swain, J. J. Nino, R. D. Prabhu, M. D. Schlachter, and T. C. Barcia. 1995. Reduction pneumonoplasty for emphysema: early results. Ann. Surg. 222: 365-374 [Medline].
3. Daniel, T. M., B. B. K. Chan, V. Bhaskar, J. S. Parekh, P. E. Walters, J. Reeder, and J. D. Truwit. 1996. Lung volume reduction surgery: case selection, operative technique and clinical results. Ann. Surg. 223: 526-533 [Medline].
4.
Miller, J. I.,
R. B. Lee, and
K. A. Mansour.
1996.
Lung volume reduction
surgery: lessons learned.
Ann. Thorac. Surg.
61:
1464-1469
5. Tschernko, E. M., W. Wisser, S. Hofer, A. Kocher, U. Watzinger, M. Kritzinger, W. Wislocki, and W. Klepetko. 1996. The influence of lung volume reduction surgery on ventilatory mechanics in patients suffering from severe chronic obstructive pulmonary disease. Anesth. Analg. 83: 996-1101 [Abstract].
6.
Roué, C.,
H. Mal,
C. Sleiman,
M. Fournier,
J.-P. Duchatelle,
P. Baldeyrou, and
R. Pariente.
1996.
Lung volume reduction in patients with severe diffuse emphysema.
Chest
110:
28-34
7.
Naunheim, K. S.,
C. A. Keller,
P. E. Krucylak,
A. Singh,
G. Ruppel, and
J. F. Osterloh.
1996.
Unilateral video-assisted thoracic surgical lung
reduction.
Ann. Thorac. Surg.
61:
1092-1098
8.
Keenan, R. J.,
R. J. Landreneau,
F. C. Sciurba,
P. F. Ferson,
J. M. Holbert,
M. L. Brown,
L. S. Fetterman, and
C. M. Bowers.
1996.
Unilateral thoracoscopic surgical approach for diffuse emphysema.
J. Thorac. Cardiovasc. Surg.
111:
308-316
9.
Sciurba, F. C.,
R. M. Rogers,
R. J. Keenan,
W. A. Slivka,
J. Gorscan,
P. F. Ferson,
J. M. Holbert,
M. L. Brown, and
R. J. Landreneau.
1996.
Improvement in pulmonary function and elastic recoil after lung-
reduction surgery for diffuse emphysema.
N. Engl. J. Med.
334:
1095-1099
10.
Hazelrigg, S.,
T. Boley,
J. Henkle,
C. Lawyer,
D. Johnstone,
K. Naunheim,
C. Keller,
R. Kennan,
R. Landreneau,
F. Sciurba,
R. Feins,
P. Levy, and
M. Magee.
1996.
Thoracoscopic laser bullectomy: a prospective study with three-month results.
J. Thorac. Cardiovasc. Surg.
112:
319-327
11.
Gelb, A. F.,
M. Brenner,
R. J. McKenna,
R. Fishel, and
J. D. Epstein.
1996.
Lung function 12 months following emphysema resection.
Chest
110:
1407-1415
12.
Benditt, J. O.,
S. Lewis,
D. E. Wood,
L. Klima, and
R. K. Albert.
1997.
Lung volume reduction surgery improves maximum O2 consumption,
maximum minute ventilation, O2 pulse and dead space-to-tidal volume ratio during leg cycle ergometry.
Am. J. Respir. Crit. Care Med.
156:
561-566
13. Wagner, P. D., D. R. Dantzker, R. Dueck, J. L. Clausen, and J. B. West. 1977. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J. Clin. Invest. 59: 203-216 .
14. Benditt, J. O., D. E. Wood, F. D. McCool, S. Lewis, and R. K. Albert. 1997. Changes in breathing and ventilatory muscle recruitment patterns induced by lung volume reduction surgery. Am. J. Respir. Crit. Care Med. 155: 279-284 [Abstract].
15. Rahn, H.. 1949. A concept of mean alveolar air and the ventilation-bloodflow relationships during pulmonary gas exchange. Am. J. Physiol. 158: 21-30 .
16.
Riley, R. L., and
A. Cournand.
1949.
`Ideal' alveolar air and the analysis
of ventilation and perfusion relationships in the lungs.
J. Appl. Physiol.
1:
825-847
17. Hlastala, M. P., and A. J. Berger. 1996. Physiology of Respiration. Oxford University Press, New York. 123-132.
18. Weg, I. L., L. Rossoff, K. McKeon, L. M. Graver, H. N. Steinberg, and S. M. Scharf. 1996. Development of pulmonary hypertension following lung volume reduction surgery. Chest 110: 57S .
19. Albert, R. K., F. Schrijen, and F. Poincelot. 1986. Oxygen consumption and transport in stable patients with chronic pulmonary disease. Am. Rev. Respir. Dis. 134: 678-682 [Medline].
20.
Gelb, A. F.,
R. J. McKenna Jr.,
M. Brenner,
R. Fischel,
A. Baydur, and
N. Zamel.
1996.
Contribution of lung and chest wall mechanics following emphysema resection.
Chest
110:
11-17
21. Gelb, A. F., N. Zamel, R. J. McKenna Jr., and M. Brenner. 1996. Mechanism of short-term improvement in lung function following emphysema resection. Am. J. Respir. Crit. Care Med. 154: 945-951 [Abstract].
This article has been cited by other articles:
![]() |
E. P. Ingenito, R. L. Berger, A. C. Henderson, J. J. Reilly, L. Tsai, and A. Hoffman Bronchoscopic Lung Volume Reduction Using Tissue Engineering Principles Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 771 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Homan, S. Porter, M. Peacock, N. Saccoia, A. M. Southcott, and R. Ruffin Increased Effective Lung Volume Following Lung Volume Reduction Surgery in Emphysema Chest, October 1, 2001; 120(4): 1157 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Butler, M. Snyder, D. E. Wood, J. R. Curtis, R. K. Albert, and J. O. Benditt Underestimation of Mortality Following Lung Volume Reduction Surgery Resulting From Incomplete Follow-up Chest, April 1, 2001; 119(4): 1056 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Travaline, A. H. Maurer, N. D. Charkes, J. L. Urbain, S. Furukawa, and G. J. Criner Quantitation of Regional Ventilation During the Washout Phase of Lung Scintigraphy : Measurement in Patients With Severe COPD Before and After Bilateral Lung Volume Reduction Surgery Chest, September 1, 2000; 118(3): 721 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. Calverley COPD : Early Detection and Intervention Chest, May 1, 2000; 117(5_suppl_2): 365S - 371S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Albert and J. O. Benditt RELATIONSHIP BETWEEN RESTING HYPERCAPNIA AND PHYSIOLOGIC PARAMETERS BEFORE AND AFTER LUNG VOLUME REDUCTION SURGERY IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 674 - 674. [Full Text] |
||||
![]() |
A. F. Gelb, R. J. McKenna Jr., M. Brenner, M. J. Schein, N. Zamel, and R. Fischel Lung Function 4 Years After Lung Volume Reduction Surgery for Emphysema* Chest, December 1, 1999; 116(6): 1608 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. CRINER, F. C. CORDOVA, S. FURUKAWA, A. M. KUZMA, J. M. TRAVALINE, V. LEYENSON, and G. M. O'BRIEN Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2018 - 2027. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |